CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- 4 Open-market sale President and CEO sold 10,000 shares at $31.75 ($317,500)
- 4 Open-market sale Chief Financial Officer sold 5,000 shares at $30.00 ($150,000)
- 4 Open-market sale SVP, Technical Operations sold 21,890 shares at $30.04 ($657,576)
- 4 Open-market sale SVP, Technical Operations sold 110 shares at $30.00 ($3,300)
- 4 Open-market sale SVP, Technical Operations sold 2,000 shares at $29.31 ($58,620)
- 4 Open-market sale President and CEO sold 10,000 shares at $27.71 ($277,100)
- 4 Open-market sale Chief Financial Officer sold 5,000 shares at $25.30 ($126,500)
- 4 Open-market sale President and CEO sold 10,000 shares at an average $32.62 ($326,184)
- 4 Open-market sale Chief Financial Officer sold 5,000 shares at $33.25 ($166,250)
- 4 Open-market sale Director sold 20,000 shares at $34.95 ($699,000)
- 4 Open-market sale Director sold 20,000 shares at $32.45 ($649,000)
- 4 Open-market sale President and CEO sold 10,000 shares at an average $29.33 ($293,273)
- 4 Open-market sale Director sold 40,000 shares at an average $28.70 ($1,148,000)
- 4 Open-market sale Chief Financial Officer sold 5,000 shares at an average $27.39 ($136,925)
- 4 Open-market sale Chief Medical Officer sold 27,342 shares at $25.00 ($683,550)
- 4 Open-market sale Director sold 20,000 shares at $24.95 ($499,000)
- 4 Open-market sale Chief Medical Officer sold 32,658 shares at $25.00 ($816,450)
- 4 Open-market sale President and CEO sold 10,500 shares at $25.00 ($262,500)
- 4 Exercise or conversion President and CEO acquired 23,530 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 15,000 shares at $20.03 ($300,450)
Page 17 of 22 · 435 filings